Recent Quarter Total Invested
$18.08 M
Recent Quarter Institutional Ownership Percentage
55.08%
Total Invested of Last Quarter
$29.39 M
Ownership Percentage of Last Quarter
58.5%
Achilles Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SYNCONA PORTFOLIO LTD | 08/13/2024 | 11.09 M | $9.04 M | 0.00% | 27.52% |
| FCPM III SERVICES B.V. | 08/08/2024 | 2.39 M | $1.95 M | 0.00% | 5.93% |
| REDMILE GROUP, LLC | 08/14/2024 | 1.61 M | $1.31 M | 0.00% | 3.99% |
| VESTAL POINT CAPITAL, LP | 08/14/2024 | 1.50 M | $1.22 M | 0.00% | 3.72% |
| IKARIAN CAPITAL, LLC | 08/14/2024 | 1.44 M | $1.18 M | 0.00% | 3.58% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 1.11 M | $903,645 | -8.27% | 2.75% |
| ARTAL GROUP S.A. | 08/14/2024 | 755,375 | $615,631 | 0.00% | 1.88% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 682,734 | $556,428 | -32.12% | 1.69% |
| BML CAPITAL MANAGEMENT, LLC | 08/07/2024 | 625,174 | $509,517 | 100.00% | 1.55% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2024 | 420,481 | $342,692 | 0.00% | 1.04% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 250,825 | $203,000 | -10.72% | 0.62% |
| UBS GROUP AG | 08/14/2024 | 65,700 | $53,546 | 100.00% | 0.16% |
| CITADEL ADVISORS LLC | 08/14/2024 | 61,391 | $50,034 | -41.53% | 0.15% |
| XTX TOPCO LTD | 08/12/2024 | 51,660 | $42,103 | 239.44% | 0.13% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 23,500 | $19,152 | 31.28% | 0.06% |
| VIRTU FINANCIAL LLC | 08/09/2024 | 22,813 | $19,000 | 8.91% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 21,590 | $17,595 | 0.00% | 0.05% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 21,478 | $17,505 | 82.03% | 0.05% |
| BAADER BANK AKTIENGESELLSCHAFT | 07/17/2024 | 12,369 | $8,210 | 100.00% | 0.03% |
| HRT FINANCIAL LP | 08/12/2024 | 10,942 | $8,000 | -70.36% | 0.03% |
| BRAVE ASSET MANAGEMENT INC | 07/15/2024 | 10,000 | $8,150 | 0.00% | 0.02% |
| MORGAN STANLEY | 10/17/2024 | 8,931 | $7,279 | -50.93% | 0.02% |
| RHUMBLINE ADVISERS | 08/01/2024 | 4,480 | $3,649 | 27.49% | 0.01% |
| GLOBAL RETIREMENT PARTNERS, LLC | 07/23/2024 | 2,000 | $1,630 | 0.00% | 0.01% |
| JPMORGAN CHASE & CO | 08/12/2024 | 137 | $112 | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 73 | $59 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| VONTOBEL HOLDING LTD. | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| RESOURCES INVESTMENT ADVISORS, LLC. | 08/02/2024 | 0 | $0 | -100.00% | 0.00% |
| FOREFRONT ANALYTICS, LLC | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
| ICA GROUP WEALTH MANAGEMENT, LLC | 08/08/2024 | 0 | $0 | -100.00% | 0.00% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
Achilles Therapeutics plcinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ACHL shares?
During the previous two years, 31 institutional investors and hedge funds held shares of Achilles Therapeutics plc. The most heavily invested institutionals were:
Global Retirement Partners, LLC: 0
Syncona Portfolio Ltd: 11.09 M
FCPM III SERVICES B.V.: 2.39 M
Redmile Group, LLC: 1.61 M
Vestal Point Capital, LP: 1.5 M
Ikarian Capital, LLC: 1.44 M
-
What percentage of Achilles Therapeutics plc stock is owned by institutional investors?
55.08% of Achilles Therapeutics plc stock is owned by institutional investors.
-
How much institutional buying is happening at ACHL ?
Institutional investors have bought a total of 22.16 M shares in the last 24 months. This purchase volume represents approximately $23.05 M in transactions.